Front Row Advisors LLC Qiagen N.V. Transaction History

Front Row Advisors LLC

7 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2023 May 22, 2023	BUY	$45.29 - $50.76 $2,672 - $2,994	59 Added 1966.67%	62 $3,000
Q1 2023 May 15, 2023	SELL	$45.29 - $50.76 $2,672 - $2,994	-59 Reduced 95.16%	3 $6,000
Q1 2019 May 17, 2019	SELL	$33.78 - $40.68 $4,560 - $5,491	-135 Reduced 68.53%	62 $3,000
Q4 2018 Feb 13, 2019	SELL	$32.65 - $37.95 $5,158 - $5,996	-158 Reduced 44.51%	197 $7,000
Q3 2018 Nov 13, 2018	SELL	$35.99 - $39.39 $35 - $39	-1 Reduced 0.28%	355 $12,000

Q1 2018 May 21, 2018	SELL	$31.01 - $34.72 $155 - $173	-5 Reduced 1.39%	356 $12,000
Q4 2017 Feb 01, 2018	BUY	$30.68 - $35.37 $11,075 - $12,768	361	361 $11,000

6.76M

Ticker QGEN
Exchange NYSE
Sector Healthcare
Industry Diagnostics & Research
Shares Outstandng 227,694,000
Market Cap $9.16B
Description
QIAGEN N.V. offers sample to insight solutions that transform biological materials into molecular insights worldwide. The company provides primary sample technology consumables, such as nucleic stabilization and purification kits for primary sample materials, manual and automated processing for genotyping, gene expression, and viral and bacteria...

Get notified when there are updates to the investment portfolio of Front Row Advisors LLC, based on Form 13F filings with the SEC.

Stay updated on Front Row Advisors LLC with notifications on news.